These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
558 related articles for article (PubMed ID: 2501478)
1. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide. Quast U; Cook NS J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478 [TBL] [Abstract][Full Text] [Related]
2. Differential effects of diazoxide, cromakalim and pinacidil on adrenergic neurotransmission and 86Rb+ efflux in rat brain cortical slices. Takata Y; Shimada F; Kato H J Pharmacol Exp Ther; 1992 Dec; 263(3):1293-301. PubMed ID: 1469635 [TBL] [Abstract][Full Text] [Related]
3. Alterations by glyburide of effects of BRL 34915 and P 1060 on contraction, 86Rb efflux and the maxi-K+ channel in rat portal vein. Hu SL; Kim HS; Okolie P; Weiss GB J Pharmacol Exp Ther; 1990 May; 253(2):771-7. PubMed ID: 2110977 [TBL] [Abstract][Full Text] [Related]
4. Effects of the K+ channel activators, RP 52891, cromakalim and diazoxide, on the plasma insulin level, plasma renin activity and blood pressure in rats. Pratz J; Mondot S; Montier F; Cavero I J Pharmacol Exp Ther; 1991 Jul; 258(1):216-22. PubMed ID: 1906538 [TBL] [Abstract][Full Text] [Related]
5. Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries. Masuzawa K; Asano M; Matsuda T; Imaizumi Y; Watanabe M J Pharmacol Exp Ther; 1990 May; 253(2):586-93. PubMed ID: 2160002 [TBL] [Abstract][Full Text] [Related]
6. Action of KC-399, a newly synthesized potassium channel opener, on mechanical activity and 86Rb efflux in rat aorta. Tamura K; Suzuki Y; Yoshida S; Nabata H J Cardiovasc Pharmacol; 1994 Feb; 23(2):220-6. PubMed ID: 7511750 [TBL] [Abstract][Full Text] [Related]
7. Potassium channel-opening and vasorelaxant profiles of a novel compound YM099 in rat isolated portal vein and rabbit isolated aorta. Uchida W; Hirano Y; Shirai Y; Taguchi T; Masuda N; Shibasaki K; Hirano S; Matsumoto Y; Tsuzuki R; Yanagisawa I Arch Int Pharmacodyn Ther; 1994; 327(3):330-43. PubMed ID: 7848015 [TBL] [Abstract][Full Text] [Related]
8. The action of diazoxide and minoxidil sulphate on rat blood vessels: a comparison with cromakalim. Newgreen DT; Bray KM; McHarg AD; Weston AH; Duty S; Brown BS; Kay PB; Edwards G; Longmore J; Southerton JS Br J Pharmacol; 1990 Jul; 100(3):605-13. PubMed ID: 2167738 [TBL] [Abstract][Full Text] [Related]
9. Effects of cromakalim, RP49356, diazoxide, glibenclamide and galanin in rat portal vein. Longmore J; Newgreen DT; Weston AH Eur J Pharmacol; 1990 Nov; 190(1-2):75-84. PubMed ID: 1706274 [TBL] [Abstract][Full Text] [Related]
10. 8-(Diethylamino)-octyl-3,4,5-trimethoxybenzoate inhibits cromakalim-induced 86Rb efflux from the rat aorta. Lodge NJ; Halaka NN J Pharmacol Exp Ther; 1993 Jun; 265(3):1399-405. PubMed ID: 8510016 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the relaxing effects of cicletanine and cromakalim on vascular smooth muscle. Deitmer P; Golenhofen K; Noack T J Cardiovasc Pharmacol; 1992 Jul; 20(1):35-42. PubMed ID: 1383629 [TBL] [Abstract][Full Text] [Related]
13. The dualistic mode of action of the vasodilator drug, nicorandil, differentiated by glibenclamide in 86Rb flux studies in rabbit isolated vascular smooth muscle. Kreye VA; Lenz T; Theiss U Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):70-5. PubMed ID: 1827659 [TBL] [Abstract][Full Text] [Related]
14. K+ channel opening mediates the vasorelaxant effects of nicorandil in the intact vascular system. Cavero I; Pratz J; Mondot S Z Kardiol; 1991; 80 Suppl 7():35-41. PubMed ID: 1838848 [TBL] [Abstract][Full Text] [Related]
15. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries. Nielsen-Kudsk JE Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816 [TBL] [Abstract][Full Text] [Related]
16. Metamizol acts as an ATP sensitive potassium channel opener to inhibit the contracting response induced by angiotensin II but not to norepinephrine in rat thoracic aorta smooth muscle. Valenzuela F; García-Saisó S; Lemini C; Ramírez-Solares R; Vidrio H; Mendoza-Fernández V Vascul Pharmacol; 2005 Aug; 43(2):120-7. PubMed ID: 15958287 [TBL] [Abstract][Full Text] [Related]
17. Binding of the K+ channel opener [3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers. Quast U; Bray KM; Andres H; Manley PW; Baumlin Y; Dosogne J Mol Pharmacol; 1993 Mar; 43(3):474-81. PubMed ID: 8450836 [TBL] [Abstract][Full Text] [Related]
18. The potassium channel openers: a new class of vasorelaxants. Weston AH; Longmore J; Newgreen DT; Edwards G; Bray KM; Duty S Blood Vessels; 1990; 27(2-5):306-13. PubMed ID: 1700735 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of BTS 67 582, a novel antidiabetic agent, in normal and diabetic rats. Jones RB; Dickinson K; Anthony DM; Marita AR; Kaul CL; Buckett WR Br J Pharmacol; 1997 Mar; 120(6):1135-43. PubMed ID: 9134227 [TBL] [Abstract][Full Text] [Related]
20. Possible involvement of ATP-sensitive K+ channels in the relaxant response of dog middle cerebral artery to cromakalim. Masuzawa K; Asano M; Matsuda T; Imaizumi Y; Watanabe M J Pharmacol Exp Ther; 1990 Nov; 255(2):818-25. PubMed ID: 2123008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]